Your search returned 112 studies. (Get alerts for new studies):
- AIGISRx Envelope for Prevention of Infection Following Replacement With a Cardiac Resynchronization Therapy Device (CRT)
Conditions: Cardiac Rhythm Management Device Infection
Location: Gadsden, Alabama
- AIGISRx Envelope for Prevention of Infection Following Replacement With an Implantable Cardioverter-Defibrillator (ICD)
Conditions: Implantable Cardioverter-Defibrillator Infection
Location: Gadsden, Alabama
- NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
Conditions: Lung Resection - Open Thoracotomy
Location: Birmingham, Alabama
- The Jetstream (JET) Post-market Registry
Conditions: Peripheral Arterial Diseases
Location: Huntsville, Alabama
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Stage IB Non-small Cell Lung Cancer - Stage IIA Non-small Cell Lung Cancer - Stage IIB Non-small Cell Lung Cancer - Stage IIIA Non-small Cell Lung Cancer
Location: Rome, Georgia
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Stage IB Non-small Cell Lung Cancer - Stage IIA Non-small Cell Lung Cancer - Stage IIB Non-small Cell Lung Cancer - Stage IIIA Non-small Cell Lung Cancer
Location: Huntsville, Alabama
- EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Conditions: Neoplasms, Breast
Location: Huntsville, Alabama
- Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Conditions: Arthritis, Rheumatoid - Osteoarthritis
Location: Huntsville, Alabama
- EXTEND (Eltrombopag Extended Dosing Study)
Conditions: Idiopathic Thrombocytopenic Purpura - Purpura, Thrombocytopenic, Idiopathic
Location: Huntsville, Alabama
- Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
Conditions: Arthritis, Rheumatoid
Location: Huntsville, Alabama
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Salivary Gland Cancer - Recurrent Squamous Cell Carcinoma of the Hypopharynx - Recurrent Squamous Cell
Location: Rome, Georgia
- Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
Conditions: Stage I Multiple Myeloma - Stage II Multiple Myeloma - Stage III Multiple Myeloma
Location: Rome, Georgia
- Prospective Observational Epidemiologic Study of Maraviroc's Safety
Conditions: Human Immunodeficiency Virus
Location: Huntsville, Alabama
- AngelMed for Early Recognition and Treatment of STEMI
Conditions: Acute Myocardial Infarction (AMI) - Coronary Occlusion - Acute Coronary Syndrome
Location: Huntsville, Alabama
- Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
Conditions: Chronic Heart Failure
Location: Huntsville, Alabama
- S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma - Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific
Location: Rome, Georgia
- Eslicarbazepine Acetate Monotherapy Long Term Study
Conditions: Epilepsy
Location: Rome, Georgia
- S0819: Carboplatin/Paclitaxel With or Without Bevacizumab and/or Cetuximab in Stage IV or Recurrent Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Rome, Georgia
- Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
Conditions: Colorectal Cancer - Precancerous Condition
Location: Rome, Georgia
- This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
Conditions: Heart Failure With Reduced Ejection Fraction
Location: Huntsville, Alabama
- Connect® MM- The Multiple Myeloma Disease Registry
Conditions: Multiple Myeloma
Location: Huntsville, Alabama
- Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodg
Conditions: Indolent Non-Hodgkin's Lymphoma - Chronic Lymphocytic Leukemia - Mantle Cell Lymphoma
Location: Huntsville, Alabama
- An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
Conditions: Chronic Lymphocytic Leukemia - Lymphoma, Non-Hodgkin - Acute Myeloid Leukemia - Multiple Myeloma
Location: Huntsville, Alabama
- AMPLATZER Cardiac Plug Clinical Trial
Conditions: Atrial Fibrillation - Ischemic Stroke - Peripheral Thromboembolism
Location: Huntsville, Alabama
- Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
Conditions: Kidney Cancer
Location: Rome, Georgia
- Efficacy and Safety of Abatacept Subcutaneous (SC) in Combination With Methotrexate in Adults With Very Early Rheumatoid Arthritis (RA)
Conditions: Rheumatoid Arthritis
Location: Huntsville, Alabama
- Safety and Efficacy Study for Solid Tumor Patients Treated With Eltrombopag
Conditions: Thrombocytopaenia
Location: Rome, Georgia
- Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
Conditions: Contrast Induced Nephropathy
Location: Huntsville, Alabama
- A Study to Compare Subcutaneous Versus Intravenous Administration of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheuma
Conditions: Rheumatoid Arthritis
Location: Huntsville, Alabama
- Evaluation of Effective Lens Position With a Uniplanar Bi-aspheric IOL
Conditions: Cataract
Location: Rome, Georgia
- Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Conditions: Colorectal Neoplasms - Digestive System Diseases - Colonic Diseases - Colorectal Cancer
Location: Huntsville, Alabama
- Maximum Tolerated Dose Study of Belinostat (PXD-101)in Combination With Paclitaxel Plus Carboplatin in Chemotherapy-Naive Patients With Stage IV Non-S
Conditions: Stage IV Non-small Cell Lung Cancer
Location: Huntsville, Alabama
- Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Conditions: Atherosclerosis
Location: Huntsville, Alabama
- DeNovo NT Longitudinal Data Collection (LDC) Knee Study
Conditions: Degenerative Lesion of Articular Cartilage of Knee - Osteochondritis Dissecans
Location: Huntsville, Alabama
- A Study of RoActemra/Actemra (Tocilizumab) in Comparison to Etanercept in Patients With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors
Conditions: Cardiovascular Disease, Rheumatoid Arthritis
Location: Huntsville, Alabama
- Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobul
Conditions: B Cell Non-Hodgkin's Lymphoma - Chronic Lymphocytic Leukemia - Waldenstrom Macroglobulinemia
Location: Huntsville, Alabama
- A Global Phase 3 Safety Study of 120 Mcg rLP2086 Vaccine in Adolescents and Young Adults Aged 10 to 25 Years
Conditions: Meningitis, Meningococcal
Location: Huntsville, Alabama
- PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
Conditions: Lymphoma
Location: Rome, Georgia
- The Effect of Reloading Prasugrel in a Patient Who Has Already Received a Loading Dose (LD) of Clopidogrel
Conditions: Acute Coronary Syndrome
Location: Huntsville, Alabama
- ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Conditions: Coronary Artery Disease
Location: Huntsville, Alabama
- Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain
Conditions: Low Back Pain
Location: Huntsville, Alabama
- Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Conditions: Coronary Artery Disease - Angina Pectoris
Location: Huntsville, Alabama
- 8-Week Study of Tolvaptan Dose Forms in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Conditions: Autosomal Dominant Polycystic Kidney Disease
Location: Huntsville, Alabama
- A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Conditions: Type 2 Diabetes
Location: Huntsville, Alabama
- Observational Study of the Use of KRYSTEXXA® in Refractory Chronic Gout
Conditions: Chronic Gout
Location: Huntsville, Alabama
- Study of Heart Failure Hospitalizations After Aquapheresis Therapy Compared to Intravenous (IV) Diuretic Treatment
Conditions: Heart Failure - Cardiac Failure - Acute Decompensated Heart Failure (ADHF)
Location: Huntsville, Alabama
- A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
Conditions: Irritable Bowel Syndrome
Location: Huntsville, Alabama
- AMR-001 Versus Placebo Post ST Segment Elevation Myocardial Infarction
Conditions: ST Segment Elevation Myocardial Infarction
Location: Huntsville, Alabama
- A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab (Avastin) Plus Platinum And Paclitaxel or With Pemetrexed Plus Platinum in Patients Wi
Conditions: Non-Small Cell Lung Cancer
Location: Huntsville, Alabama
- Study of the Safety, Tolerability, and Efficacy of MK-7655 + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone for the Treatment of Complicated Uri
Conditions: Urinary Tract Infections - Pyelonephritis
Location: Huntsville, Alabama
- Study of the Safety, Tolerability, and Efficacy of MK-7655 + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone to Treat Complicated Intra-Abdominal
Conditions: Intra-abdominal Infections
Location: Huntsville, Alabama
- Long-term Safety and Tolerability of SAR236553 (REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in High Cardiovascular Risk Patients With Hy
Conditions: Hypercholesterolemia
Location: Huntsville, Alabama
- Combining Lesinurad With Allopurinol in Inadequate Responders
Conditions: Gout
Location: Hunstville, Alabama
- A Study of Onartuzumab (MetMAb) Versus Placebo in Combination With Paclitaxel Plus Platinum in Patients With Squamous Non-Small Cell Lung Cancer
Conditions: Non-Small Cell Lung Cancer
Location: Huntsville, Alabama
- Shortened Aggrastat® Versus Integrilin in Percutaneous Coronary Intervention
Conditions: Myocardial Infarction - Acute Coronary Syndromes - Unstable Angina
Location: Rome, Georgia
- A Pharmacokinetic/Pharmacodynamic Study Comparing PF-05280586 To Rituximab In Subjects With Active Rheumatoid Arthritis With An Inadequate Response To
Conditions: Rheumatoid Arthritis
Location: Huntsville, Alabama
- A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemi
Conditions: Chronic Lymphocytic Leukemia
Location: Huntsville, Alabama
- Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
Conditions: Irritable Bowel Syndrome With Diarrhea
Location: Huntsville, Alabama
- Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d) (Protocol J
Conditions: Irritable Bowel Syndrome
Location: Huntsville, Alabama
- Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d) (Protocol J
Conditions: Irritable Bowel Syndrome
Location: Huntsville, Alabama
- Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d) (Protocol J
Conditions: Irritable Bowel Syndrome
Location: Huntsville, Alabama
- A Extension Study of Idelalisib for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
Conditions: Chronic Lymphocytic Leukemia
Location: Huntsville, Alabama
- A Phase 3 Study Comparing Oral MLN9708 Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With R
Conditions: Relapsed Multiple Myeloma - Refractory Multiple Myeloma
Location: Huntsville, Alabama
- A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Ly
Conditions: Chronic Lymphocytic Leukemia
Location: Huntsville, Alabama
- Safety and Efficacy of the Accent Magnetic Resonance Imaging™ (MRI) Pacemaker and Tendril MRI™ Lead
Conditions: Adverse Effect of MRI on an Implanted Pacemaker Lead - Adverse Effect of MRI on an Implanted Pacemaker
Location: Huntsville, Alabama
- Randomized, Double-Blind, Placebo Controlled Study of the Short Term Clinical Effects of Tolvaptan in Patients Hospitalized for Worsening Heart Failur
Conditions: Heart Failure
Location: Huntsville, Alabama
- NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
Conditions: Atrial Fibrillation - Paroxysmal Arrhythmia
Location: Huntsville, Alabama
- PROMUS Element Plus US Post-Approval Study
Conditions: Coronary Artery Disease
Location: Huntsville, Alabama
- Monthly And Twice Monthly Subcutaneous Dosing Of PF-04950615 (RN316) In Hypercholesterolemic Subjects On A Statin
Conditions: Hypercholesterolemia
Location: Huntsville, Alabama
- Efficacy and Safety of TBS-2 Testosterone Gel in Women With Acquired Female Orgasmic Disorder
Conditions: Female Orgasmic Disorder
Location: Huntsville, Alabama
- Evaluation of Patient Retention of Fingolimod vs. Currently Approved Disease Modifying Therapy in Patients With Relapsing Remitting Multiple Sclerosis
Conditions: Relapsing Remitting Multiple Sclerosis
Location: Huntsville, Alabama
- Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus
Conditions: Type 2 Diabetes Mellitus - Hepatitis B
Location: Huntsville, Alabama
- MS Study Evaluating Safety and Efficacy of Two Doses of Fingolimod Versus Copaxone
Conditions: Relapsing-remitting Multiple Sclerosis (RRMS)
Location: Huntsville, Alabama
- A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Anti-TNFa Biologics
Conditions: Inflammation - Rheumatoid Arthritis
Location: Huntsville, Alabama
- Sacroiliac Joint Fusion With iFuse Implant System (SIFI)
Conditions: Degenerative Sacroiliitis - Sacroiliac Joint Disruption
Location: Huntsville, Alabama
- Rheumatoid Arthritis Extension Trial For Subjects Who Have Participated In Other PF-05280586 Trials (REFLECTIONS B328-04)
Conditions: Rheumatoid Arthritis
Location: Huntsville, Alabama
- Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Conditions: Abdominal Aortic Aneurysm - Aorto-iliac Aneurysm
Location: Huntsville, Alabama
- Comparison Study of the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Typ
Conditions: Diabetes Type 2
Location: Huntsville, Alabama
- Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Conditions: Management of Anemia in Chronic Kidney Disease Patients Not on Dialysis.
Location: Huntsville, Alabama
- Evaluation of Ultrafast Hypothermia Before Reperfusion in STEMI Patients
Conditions: ST-elevation MI - Hypothermia
Location: Huntsville, Alabama
- Phase 2 Efficacy Trial of Z160 in Lumbosacral Radiculopathy
Conditions: Lumbosacral Radiculopathy
Location: Huntsville, Alabama
- Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With SAR236553 (REGN727) (ODYSSEY Outcomes)
Conditions: Acute Coronary Syndrome
Location: Huntsville, Alabama
- Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation
Conditions: Chronic Idiopathic Constipation
Location: Huntsville, Alabama
- A Study of Evacetrapib in High-Risk Vascular Disease
Conditions: Cardiovascular Diseases
Location: Huntsville, Alabama
- Phase 2 Study of TD-9855 to Treat Fibromyalgia
Conditions: Fibromyalgia
Location: Huntsville, Alabama
- Safety and Efficacy Study of GRT6005 in Patients With Osteoarthritis (OA) Knee Pain
Conditions: Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee
Location: Huntsville, Alabama
- A 12-week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and T
Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Location: Huntsville, Alabama
- A Study of the Efficacy and Safety of MK-0431D (a Fixed-dose Combination of Sitagliptin and Simvastatin) for the Treatment of Participants With Type 2
Conditions: Type 2 Diabetes Mellitus
Location: Huntsville, Alabama
- Safety & Efficacy of Zirconium Silicate in Mild to Moderate Hyperkalemia
Conditions: Hyperkalemia
Location: Huntsville, Alabama
- Safety Study of CC-292 and Rituximab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Conditions: Leukemia Lymphocytic Chronic B-Cell
Location: Huntsville, Alabama
- Ublituximab in Combination With Lenalidomide in Patients With B-Cell Lymphoid Malignancies
Conditions: Non-Hodgkins Lymphoma - Chronic Lymphocytic Leukemia - Small Lymphocytic Lymphoma - B-cell Lymphomas - Marginal Zone Lymphoma - Mantle Cell Lymphoma - Waldenstrom's Macroglobulinemia
Location: Huntsville, Alabama
- Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk
Conditions: Dyslipidemia
Location: Huntsville, Alabama
- Safety and Efficacy Trial of Testosterone Undecanoate
Conditions: Male Hypogonadism
Location: Huntsville, Alabama
- A Study Evaluating the Efficacy and Safety of Idelalisib (GS-1101) in Combination With Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas
Conditions: Indolent Non-Hodgkin's Lymphomas
Location: Huntsville, Alabama
- To Evaluate The Safety of SAR153191 (REGN88) and Tocilizumab Added to Other RA Drugs in Patients With RA Who Are Not Responding to or Intolerant of An
Conditions: Rheumatoid Arthritis
Location: Huntsville, Alabama
- Study of the Efficacy and Safety of Ublituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
Conditions: Non-Hodgkins Lymphoma - B-cell Lymphoma - Waldenstrom's Macroglobulinemia - Marginal Zone Lymphoma - Chronic Lymphocytic Leukemia - Small Lymphocytic Lymphoma - Primary Central Nervous System Lymphoma
Location: Huntsville, Alabama
- Safety Study of CC-292 and Lenalidomide in Subjects With Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma
Conditions: Leukemia Lymphocytic Chronic B-Cell
Location: Huntsville, Alabama
- A Study Evaluating the Efficacy and Safety of Idelalisib(GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-H
Conditions: Indolent Non-Hodgkin's Lymphomas
Location: Huntsville, Alabama
- Access Safety and Efficacy Post Endovascular Intervention
Conditions: Cardiovascular Disease.
Location: Huntsville, Alabama
- Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076 AM1)
Conditions: Osteoporosis
Location: Huntsville, Alabama
- Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Conditions: Arthritis, Rheumatoid - Osteoarthritis
Location: Rome, Georgia
- Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Conditions: Arthritis, Rheumatoid - Osteoarthritis
Location: Rome, Georgia
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Distal Urethral Cancer - Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter - Proximal Urethral Cancer - Recurrent Bladder Cancer - Recurrent Prostate Cancer - Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter - Recurrent U
Location: Rome, Georgia
- A Study in Second Line Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Rome, Georgia
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can
Location: Rome, Georgia
- A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Conditions: Advanced Prostate Cancer - Prostatic Neoplasms
Location: Rome, Georgia
- A Study of RoActemra/Actemra (Tocilizumab) in Comparison to Etanercept in Patients With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors
Conditions: Cardiovascular Disease, Rheumatoid Arthritis
Location: Rome, Georgia
- A Study to Test Safety and Efficacy of Baricitinib in Participants With Diabetic Kidney Disease
Conditions: Diabetic Kidney Disease
Location: Chattanooga, Tennessee
- A Study of MK-3102 in Participants With Type 2 Diabetes Mellitus With Chronic Kidney Disease or Kidney Failure on Dialysis (MK-3102-019 AM3)
Conditions: Type 2 Diabetes Mellitus
Location: Chattanooga, Tennessee
- A Study of LY2940680 in Small Cell Lung Cancer
Conditions: Small Cell Lung Carcinoma
Location: Rome, Georgia
- A Study of Necitumumab and Chemotherapy in Participants With Stage IV Squamous Non-Small Cell Lung Cancer
Conditions: Squamous Non Small Cell Lung Cancer
Location: Rome, Georgia
- Study the Characteristics of Cardiac Related Events in Hemodialysis Patients
Conditions: End Stage Renal Disease
Location: Chattanooga, Tennessee
|